How drugmakers come up with evocative brand names like Viagra and Lunesta
Featured Posts




Help to find a new name for the monkeypox virus


How Do Drugs Get Named?


Sanofi launches Impact® brand of medicines for low-income countries

Branded Generics: What They Are and Why They’re Profitable


The top 20 drugs by worldwide sales in 2021


Drug submissions: Procedures to reach regulatory approval


How pharmaceutical names influence the way consumers and doctors view medicines


All in a name: safety first

Drug Name Development: Regulatory Changes You Need to Know


Drug repurposing and skinny labels


Pharma product launch optimisation tool


Naming Your Brand

Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency


How does the FDA 'approve' medical products?


The Secret Formula Behind Every Drug Name


Branding and design in the medical/pharma industry


Pharma Brand Strategy 2.0


What Is an Active Pharmaceutical Ingredient (API)?


The Drug Naming Process


The twists and turns of naming diseases


Branding: When One is Not Enough


Liposomal medicine names to be changed to avoid errors


The difference between pharmaceutical and biotechnology


Biosimilar names may affect pharmacist dispensing habits


Branders give products an identity


The top 10 drugs of 2024


FDA Draft Guidance Requiring Distinct Naming for Biosimilars


A drug by any other name would work just as well — making sense of drug names


FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested


Can you teach old drugs new tricks?

'Accelerated approval' drugs: How well are they studied?


The FDA just approved the first direct competitor to a billion-dollar cancer drug

Role of brand is 57% more likely to influence a recommendation compared to two years ago

What’s in a name? Billions of dollars in tech costs for biosimilars


How drug development is speeding up in the cloud

Globalization in the pharmaceutical industry


Why Biosimilar Drug Names Contain Unhelpful Gibberish


Behind potent drug names, a complex mix of ingredients


Introducing The New Association For Accessible Medicines (AAM)


FDA Reiterates Decision on Suffixes in Biosimilar Naming


Behind potent drug names, a complex mix of ingredients


New diagnostic name for stigmatizing term obesity


The creative science of coining drug names


UK medicines regulation: responding to current challenges


Probiotics in Favor of Life


Maintaining Relevance In The Age Of Consumerism: Lessons From The Healthcare Industry


'Creation engineering': The art and science of naming drugs


Neuropathy: A name for their pain


FDA approves first automated insulin delivery device for type 1 diabetes